Park; Bum Joon

Patent Applications and Registrations

Patent applications and USPTO patent grants for Park; Bum Joon.The latest application filed is for "pharmaceutical composition for preventing or treating aging-related diseases containing decursin derivative as active ingredient".

Company Profile

3.9.11

Park; Bum Joon - Busan KR
Park; Bum-Joon - Anyang-si KR
Park; Bum Joon - Gyeonggi-do KR
PARK; Bum-Joon - Chungcheongbuk-do KR
Park; Bum-Joon - Seoul KR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Pharmaceutical composition for preventing or treating aging-related diseases containing decursin derivative as active ingredient Grant 11,008,332 - Park , et al. May 18, 2	2021-05-18
Coil spacer structure for molding transformer Grant 10,943,728 - Park March 9, 2	2021-03-09
Pharmaceutical Composition For Preventing Or Treating Aging-related Diseases Containing Decursin Derivative As Active Ingredient App 20200048274 - PARK; Bum Joon ; et al.	2020-02-13
Compound for inhibiting binding between DX2 protein and p14/ARF protein, and pharmaceutical composition for treating or preventing cancer disease containing same as effective ingredient Grant 10,280,178 - Park , et al.	2019-05-07
New Compound For Inhibiting Binding Between Dx2 Protein And P14/arf Protein, And Pharmaceutical Composition For Treating Or Preventing Cancer Disease Containing Same As Effective Ingredient App 20180362540 - PARK; Bum Joon ; et al.	2018-12-20
Coil Spacer Structure For Molding Transformer App 20180286571 - PARK; Bum-Joon	2018-10-04
Compound for inhibiting binding between DX2 protein and P14/ARF protein, and pharmaceutical composition for treating or preventing cancer disease containing same as effective ingredient Grant 10,072,021 - Park , et al. September 11, 2	2018-09-11
New Compound For Inhibiting Binding Between Dx2 Protein And P14/arf Protein, And Pharmaceutical Composition For Treating Or Preventing Cancer Disease Containing Same As Effective Ingredient App 20170129904 - PARK; Bum Joon ; et al.	2017-05-11
Apparatus and method for treating substrate Grant 9,508,541 - Lee , et al. November 29, 2	2016-11-29
Method of screening of therapeutic agents for K-Ras mutant driven cancers Grant 9,400,281 - Park , et al. July 26, 2	2016-07-26
Pharmaceutical composition for treating aging-associated diseases, containing progerin expression inhibitor as active ingredient, and screening method of said progerin expression inhibitor Grant 9,249,153 - Park , et al. February 2, 2	2016-02-02
Searching Information Using Smart Glasses App 20150186426 - JEONG; Yeong-Hwan ; et al.	2015-07-02
Apparatus And Method For Treating Substrate App 20140190513 - Lee; Jongjin ; et al.	2014-07-10
Compound For Inhibiting Snail-p53 Binding And Therapeutic Agent For Cancer Including The Compound As Effective Component App 20140147866 - PARK; Bum Joon ; et al.	2014-05-29
Pharmaceutical Composition For Treating Aging-associated Diseases, Containing Progerin Expression Inhibitor As Active Ingredient, And Screening Method Of Said Progerin Expression Inhibitor App 20140039010 - Park; Bum Joon ; et al.	2014-02-06
Chemical Inhibitor Of P53-snail Binding And Pharmaceutical Composition For Treating Cancer Disease Containing Same As Its Active Ingredient App 20120015960 - Park; Bum Joon ; et al.	2012-01-19
Method for treating cancer using p38/JTV-1 and method for screening pharmaceutical composition for treating cancer Grant 7,196,068 - Kim , et al. March 27, 2	2007-03-27
Method for treating cancer using p38/JTV-1 and method for screening pharmaceutical composition for treating cancer App 20040175375 - Kim, Sunghoon ; et al.	2004-09-09

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.